These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: [New oral cephem antibiotic, cefroxadine capsules, against superficial suppurative disease in the field of surgery].
    Author: Abe N, Sakurai K.
    Journal: Jpn J Antibiot; 1983 Sep; 36(9):2515-20. PubMed ID: 6655866.
    Abstract:
    Cefroxadine was administered at dose level of 750 mg/day to 21 cases of superficial suppurative diseases and the following results were obtained: The effective rate determined by the treating doctor was 9/21 (42.9%). The effective rate by the evaluation standard was 12/21 (57.1%). The negative-conversion rate was 11/11 (100%) in the 11 cases in which bacteriological effects were clarified. No side effects were observed in all of the 21 cases.
    [Abstract] [Full Text] [Related] [New Search]